The rising threat of antibiotic and multidrug resistance in neonatal urinary tract infections

dc.contributor.authorSaglam, Mukaddes Kilic
dc.contributor.authorYanasoglu, Emine
dc.contributor.authorSav, Nadide Melike
dc.contributor.authorKurt, Fatih
dc.contributor.authorKocabay, Kenan
dc.contributor.authorAkbas, Emel
dc.contributor.authorSungur, Mehmet Ali
dc.date.accessioned2026-07-01T11:39:39Z
dc.date.available2026-07-01T11:39:39Z
dc.date.issued2025
dc.departmentDüzce Üniversitesi
dc.description.abstractObject & imath;veUrinary tract infections (UTIs) are one of the significant causes of sepsis in neonates. Currently, antimicrobial resistance (AMR) and multidrug-resistant (MDR) microorganisms have become an increasingly prevalent issue in newborns. This study aimed to evaluate the clinical and laboratory findings, causative organisms, associated urinary tract anomalies, AMR patterns, and factors influencing the development of MDR in neonatal UTIs.MethodsMicroorganisms in urine cultures obtained through bladder catheterization from neonates were identified, and AMR profiles as well as MDR organisms were determined. Antibiotic susceptibility tests were performed using Kirby-Bauer disk diffusion method and VITEK 2 Compact system. The cultures were categorized into two groups: MDR and non-MDR. A retrospective evaluation was conducted to assess the impact of clinical, laboratory, and imaging data on the development of MDR.ResultsData from 51 neonatal UTIs between 2018 and 2024 were evaluated. The most common microorganisms were Esherichia coli (E. Coli) and Klebsiella pneumoniae (K. Pneumoniae). A total of 75% of the E. coli strains demonstrated resistance to ampicillin. Resistance rates of E. coli, K. pneumoniae, and Enterobacter spp. to gentamicin was 25%, 30.7%, and 80%, respectively. Among the microorganisms 55% of E. coli, 100% of Enterobacter spp., 38.5% of K. pneumoniae, and 20% of Enterococcus spp. were MDR. However, no significant correlation was found between MDR and clinical, laboratory, and imaging data. Blood cultures were obtained from all patients prior to the initiation of antibiotic therapy; however, no pathogenic microorganisms were isolated.ConclusionsAMR and MDR in neonatal UTIs appear to be a serious problem. Treatment options in MDR UTIs remain limited, and it is particularly important to research on the pharmacokinetics and safety profiles of antimicrobials in children is essential to expand treatment options for pediatric populations worldwide.
dc.identifier.doi10.1186/s12887-025-06210-6
dc.identifier.issn1471-2431
dc.identifier.issue1
dc.identifier.orcid0000-0002-7231-5461
dc.identifier.pmid41111142
dc.identifier.scopus2-s2.0-105019191137
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1186/s12887-025-06210-6
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23399
dc.identifier.volume25
dc.identifier.wosWOS:001595909500001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmc
dc.relation.ispartofBmc Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260623
dc.subjectNeonatal
dc.subjectUrinary Tract Infection
dc.subjectAntibiotic Resistance
dc.subjectMultidrug Resistance
dc.titleThe rising threat of antibiotic and multidrug resistance in neonatal urinary tract infections
dc.typeArticle

Dosyalar